Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 847

1.

Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.

Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA.

J Cell Biol. 2000 Feb 21;148(4):779-90. Erratum in: J Cell Biol 2000 Apr 3;149(1):following 236.

2.
3.

Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.

Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.

Clin Cancer Res. 2001 Sep;7(9):2840-53.

4.

Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.

Zuo J, Ishikawa T, Boutros S, Xiao Z, Humtsoe JO, Kramer RH.

Mol Cancer Res. 2010 Feb;8(2):170-82. doi: 10.1158/1541-7786.MCR-09-0354. Epub 2010 Feb 9.

5.

N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.

Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ.

J Cell Biol. 1999 Nov 1;147(3):631-44.

6.

Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.

Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP, Byers SW.

Cell Growth Differ. 1991 Aug;2(8):365-72.

7.

Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.

Zhang K, Chen D, Jiao X, Zhang S, Liu X, Cao J, Wu L, Wang D.

Lab Invest. 2011 Mar;91(3):426-38. doi: 10.1038/labinvest.2010.201. Epub 2011 Jan 31. Retraction in: Lab Invest. 2012 Dec;92(12):1801.

8.
11.

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T.

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

12.
13.

E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.

Cancer Res. 1996 Sep 1;56(17):4063-70.

14.

Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.

Rao Y, Wang H, Fan L, Chen G.

J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):1-9. doi: 10.1007/s11596-011-0141-9. Epub 2011 Feb 19.

PMID:
21336715
15.

[Effect of HIF-1α and its mechanism on invasion and metastasis of esophageal carcinoma Eca109 cells in vitro and in vivo].

Jing SW, Wang YD, Zheng MM, Sun GG, Liu Q, Cheng YJ, Yang CR.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jan;28(1):67-71. Chinese.

PMID:
22230507
17.

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.

Cancer Res. 2009 Nov 15;69(22):8742-51. doi: 10.1158/0008-5472.CAN-09-1541. Epub 2009 Nov 3.

18.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.

19.

Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Meng Y, Gu C, Wu Z, Zhao Y, Si Y, Fu X, Han W.

BMC Cancer. 2009 Mar 4;9:75. doi: 10.1186/1471-2407-9-75.

20.

Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.

Leppä S, Vleminckx K, Van Roy F, Jalkanen M.

J Cell Sci. 1996 Jun;109 ( Pt 6):1393-403.

Supplemental Content

Support Center